Description

The fund primarily aims to achieve its investment objectives by allocating a minimum of 80% of its net capital (which may include funds borrowed for investment purposes) to securities of companies that its portfolio manager identifies as having a strong orientation towards life sciences. Additionally, as a core principle, the fund generally pledges to invest at least 25% of its overall assets in businesses specifically categorized within the "life sciences" sector.